For example, individuals using 15 mg of Tirzepatide once a week lost an average of 11.2 kg of weight, which was better than other therapies
Full EVOKE/EVOKE+ results are likely to be discussed further at upcoming scientific meetings (e.g., AD/PD 2026), and ongoing analyses may explore preventive settings (earlier intervention), dose/exposure considerations (e.g., injectable vs
The AJCN Advisory is clear: protein + physical activity are not optional add-ons, they are core pillars of safe and effective GLP-1 therapy
Patients can have their questions answered in seconds and receive treatment recommendations tailored to their unique health profile
A cell surface antigen belonging to the immunoglobulin superfamily of molecules
This is where the need for extra aid like vitamin D injections comes into play